In human breast cancer cells, curcumin was found to effectively inhibit the expression of several Wnt/β-catenin pathway components such as disheveled, beta-catenin, cyclin D1, and slug in both MCF-7 and MDA-MB-231 breast cancer cell lines [166]. Here, CCND1 is linked to breast carcinoma.